Primary and secondary liver failure after major liver resection for perihilar cholangiocarcinoma

Surgery (United States)

Volumn 170, Issue 4, 2021, Pages 1024-1030

  van Keulen, Anne Marleen ^a,b   Buettner, Stefan ^a,b   Besselink, Marc G ^c   Busch, Olivier R ^c   van Gulik, Thomas M ^c   IJzermans, Jan N M ^b   de Jonge, Jeroen ^b   Polak, Wojciech G ^b   Swijnenburg, Rutger Jan ^c   Erdmann, Joris I ^c   Groot Koerkamp, Bas ^b   Olthof, Pim B ^b,c  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b ERASMUS MC CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; CHOLANGITIS; CONTROLLED STUDY; DISEASE COURSE; ECOG PERFORMANCE STATUS; FEMALE; HUMAN; INCIDENCE; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OPERATIVE BLOOD LOSS; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE COMPLICATION; RISK FACTOR; SEPSIS; TERTIARY CARE CENTER; ADVERSE EVENT; BILE DUCT CANCER; CANCER STAGING; CLINICAL TRIAL; FOLLOW UP; KLATSKIN TUMOR; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME;

AGED; BILE DUCT NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INCIDENCE; KLATSKIN TUMOR; LIVER FAILURE; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85106383258     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2021.04.013     Document Type: Article

References (29)

1. Khan, S.A., Thomas, H.C., Davidson, B.R., Taylor-Robinson, S.D., Cholangiocarcinoma. Lancet, 366, 2005 1303–1214.
2. Mansour, J.C., Aloia, T.A., Crane, C.H., Heimbach, J.K., Nagino, M., Vauthey, J.N., Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17 (2015), 691–699.
3. Franken, L.C., Schreuder, A.M., Roos, E., et al. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: a systematic review and meta-analysis. Surgery 165 (2019), 918–928.
4. Olthof, P.B., Coelen, R.J., Wiggers, J.K., Besselink, M.G., Busch, O.R., van Gulik, T.M., External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage. HPB (Oxford) 18 (2016), 348–353.
5. Higuchi, R., Yamamoto, M., Indications for portal vein embolization in perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21 (2014), 542–549.
6. Yokoyama, Y., Nishio, H., Ebata, T., Igami, T., Sugawara, G., Nagino, M., Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg 97 (2010), 1260–1268.
7. Olthof, P.B., Coelen, R.J.S., Bennink, R.J., et al. (99m)Tc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma. HPB (Oxford) 19 (2017), 850–858.
8. Franken, L.C., Rassam, F., van Lienden, K.P., et al. Effect of structured use of preoperative portal vein embolization on outcomes after liver resection of perihilar cholangiocarcinoma. BJS Open 4 (2020), 449–455.
9. Olthof, P.B., Aldrighetti, L., Alikhanov, R., et al. Correction to: portal vein embolization is associated with reduced liver failure and mortality in high-risk resections for perihilar cholangiocarcinoma. Ann Surg Oncol, 27, 2020, 968.
10. Kauffmann, R., Fong, Y., Post-hepatectomy liver failure. Hepatobiliary Surg Nutr 3 (2014), 238–246.
11. Guglielmi, A., Ruzzenente, A., Conci, S., Valdegamberi, A., Iacono, C., How much remnant is enough in liver resection?. Dig Surg 29 (2012), 6–17.
12. Wiggers, J.K., Groot Koerkamp, B., Cieslak, K.P., et al. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg 223 (2016), 321–331.e1.
13. de Graaf, W., van Lienden, K.P., Dinant, S., et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 14 (2010), 369–378.
14. Koch, M., Garden, O.J., Padbury, R., et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149 (2011), 680–688.
15. Rahbari, N.N., Garden, O.J., Padbury, R., et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149 (2011), 713–724.
16. Rahbari, N.N., Garden, O.J., Padbury, R., et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) 13 (2011), 528–535.
17. Oken, M.M., Creech, R.H., Tormey, D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982), 649–655.
18. Olthof, P.B., Miyasaka, M., Koerkamp, B.G., et al. A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers. HPB (Oxford) 21 (2019), 345–351.
19. Mohkam, K., Rayar, M., Adam, J.P., et al. Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT). BMC Cancer, 18, 2018, 844.
20. Chen, W., Ke, K., Chen, Y.L., Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol 40 (2014), 489–495.
21. Rassam, F., Olthof, P.B., Bennink, R.J., van Gulik, T.M., Current modalities for the assessment of future remnant liver function. Visc Med 33 (2017), 442–448.
22. Olthof, P.B., Wiggers, J.K., Groot Koerkamp, B., et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J Am Coll Surg 225 (2017), 387–394.
23. Cieslak, K.P., Bennink, R.J., de Graaf, W., et al. Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. HPB (Oxford) 18 (2016), 773–780.
24. Wrighton, L.J., O'Bosky, K.R., Namm, J.P., Senthil, M., Postoperative management after hepatic resection. J Gastrointest Oncol 3 (2012), 41–47.
25. Garwood, R.A., Sawyer, R.G., Thompson, L., Adams, R.B., Infectious complications after hepatic resection. Am Surg 70 (2004), 787–792.
26. Yanaga, K., Kanematsu, T., Takenaka, K., Sugimachi, K., Intraperitoneal septic complications after hepatectomy. Ann Surg 203 (1986), 148–152.
27. de Boer, M.T., Molenaar, I.Q., Porte, R.J., Impact of blood loss on outcome after liver resection. Dig Surg 24:4 (2007), 259–264.
28. Ribero, D., Zimmitti, G., Aloia, T.A., et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg 223 (2016), 87–97.
29. Coelen, R.J.S., Roos, E., Wiggers, J.K., et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol 3 (2018), 681–690.